The Latest News from Our Field

We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.

The Biden administration is calling on states to use Medicaid funds to cover opioid addiction treatment in correctional facilities, The New York Times reports.
The National Academies of Sciences, Engineering, and Medicine, which advised the White House and Congress on responding to the opioid crisis, accepted $19 million in donations from members of the Sackler family, owners of OxyContin maker Purdue Pharma, The New York Times reports.
The rate of suspected suicide attempts by poisoning among children and teens ages 10 to 19 rose 30% in 2021 compared with prepandemic rates, a new study finds.
Find more of our must-reads in policy news, including the limited steps taken by the federal government to guide opioid settlement funds.
View our curated digest of the latest research news, including a study on factors associated with support for harm reduction and recovery services in a rural community.
The American Academy of Pediatrics this week called for greater federal regulations to reduce tobacco use and nicotine exposure in children and teens, CNN reports.
Offering medication to treat opioid addiction in jails and prisons reduces overdose deaths, a new study finds.
Hospitals are more likely to test Black pregnant people for substance use compared with pregnant people who are white, a new study finds. Researchers said the difference is due to racial bias, The New York Times reports.
Find more of our must-reads in policy news, including new guidance by The Centers for Medical and Medicaid Services encouraging states to provide Medicaid coverage for individuals who are incarcerated prior to their reentry.
View our curated digest of the latest research news, including a study on drug-related adverse effects among nightclub and festival attendees.
The White House on Wednesday designated fentanyl mixed with the animal tranquilizer xylazine to be an emerging threat to the United States, CNN reports.
Real estate developers are working with health care providers and state and local governments to open more addiction recovery centers, psychiatric facilities and other behavioral health clinics to meet growing demand, The New York Times reports.
A Drug Enforcement Administration proposal that would limit telehealth prescriptions for buprenorphine to an initial 30-day supply until the patient can be seen in person by a physician is raising concerns among addiction medicine advocates, Roll Call reports.
Find more of our must-reads in policy news, including the ONDCP declaring fentanyl combined with xylazine an emerging threat.
View our curated digest of the latest research news, including a study on the association between hospitals adopting an emergency department buprenorphine treatment pathway and patients' subsequent initiation of buprenorphine treatment.
A new study finds the expanded availability of opioid use disorder-related telehealth services and medications during the pandemic were associated with a lower risk of fatal overdoses among Medicare patients.
Scientists evaluating more than 100 studies of alcohol consumption conclude that there are no significant health benefits to drinking moderately, ABC News reports.
More than $50 billion in settlement money is being delivered from opioid corporations to states and localities, yet only 12 states have committed to detailed public reporting on where their opioid settlement funding is going, Kaiser Health News reports.
Find more of our must-reads in policy news, including a federal judge striking down the ACA preventive services mandate.
View our curated digest of the latest research news, including a scoping review of implementation considerations for harm reduction vending machines.
The U.S. Food and Drug Administration on Wednesday approved the first over-the-counter naloxone nasal spray, The New York Times reports.
Test strips will soon be available to detect the presence of the animal sedative xylazine, also known as tranq, in illicit substances, STAT reports.
People who survive an opioid overdose have a lower risk of dying from a subsequent overdose if they are treated with the opioid addiction medication buprenorphine, a new study suggests.
Find more of our must-reads in policy news, including the FDA approving Narcan naloxone nasal spray for over-the-counter, nonprescription use.
View our curated digest of the latest research news, including a study on the ecological momentary assessment of heavy episodic drinking in the early postpartum period by Sarah Dauber, Vice President of Research and Evaluation at the Partnership to End Addiction.